For patients with relapsed or refractory CD7-positive leukemia or lymphoma, sequential CD7 chimeric antigen receptor (CAR) T-cell therapy followed by haploidentical hematopoietic stem-cell transplantation (HSCT) is safe and ...
Apr 25, 2024
0
1
Chemokines are signaling proteins that orchestrate the interaction of immune cells against pathogens and tumors. To understand this complex network, various techniques have been developed to identify chemokine-producing cells.
Apr 25, 2024
0
6
In a recent study published in the Science Bulletin, researchers comprehensively examined the composition and phenotypic features of myeloid cells in human failing hearts at a single-cell level, offering valuable insights ...
Apr 24, 2024
0
0
Allergy season can bring misery to tens of millions of Americans each year.
Apr 24, 2024
0
0
B cells are part of the immune system's memory. Their memories of previous infections or vaccinations provide the template for antibodies that have a protective effect the next time they come into contact with a pathogen.
Apr 23, 2024
0
1
A study by researchers at National Jewish Health published in the Annals of Allergy, Asthma & Immunology reports that air pollutants—including particulate matter, pollen, greenhouse gases, and other harmful substances—can ...
Apr 22, 2024
0
0
New research being presented at this year's ESCIMD Global Congress (formerly ECCMID) in Barcelona, Spain (27–30 April), finds that the odds of death in Black women with a bloodstream infection (BSI) caused by carbapenem-resistant ...
Apr 19, 2024
0
0
For the roughly 1.5 million Americans per year who survive a traumatic brain injury, health outcomes vary widely. Not only can these injuries lead to a loss of coordination, depression, impulsivity, and difficulty concentrating, ...
Apr 19, 2024
0
10
A collaborative research team has pioneered a new stem cell model to help personalize treatment for patients suffering from rare forms of immunodeficiency. The research findings were published in the Journal of Allergy and ...
Apr 19, 2024
0
0
Non-small cell lung cancer accounts for nearly 85% of all lung cancer cases. Targeted immunotherapy is a common treatment, but it does not work for everyone. However, a new Moffitt Cancer Center study published in the journal ...
Apr 18, 2024
0
4
